4Knoll RH, Hoshijima M, Chien KR. Mechanism of dilated cardiomyopathies Drug Discovery Today: Disease Mechanism? Cardiovascular diseases,2004,1:31
5Akar FG, Tomaselli GF. Conduction abnormalities in nonischemic dilated cardiomyopathy: basic mechanisms and arrhythmic consequences. TCM,2005,15:259
6Kawada T, Nakazawa M, Nakauchi Set al . Rescue of hereditary form of dilated cardiomyopathy by rAAV- mediated somatic gene therapy:amelioration of morphological findings,sarcolemmal, permeability, cardiac performances , and the prognosis of TO22 hamsters. Proc Natl Acad Sci USA,2002, 99(2) :901
7Kawada T, Nakazawa M, Toyo Oka T. Somatic gene therapy of dilated cardiomyopathy. Japan J Phann,2002,119( 1 ) :37
8Dorffel W,Felix S,Wallukat Get al .Short- term hemodynamic effects of immtmoab sorption in dilated cardiomyopathy. Circulation , 1997 ,95(8): 1994
9Otaki KJ, Tsukube T, Okita Yet al . Girdling effect of dynamic cardiomyopathy in a model of dilated cardiomyopathy. Japan J Thorgcic Cardiovasc Surg,2002,50(3) : 104
10Linde C, Leclercq C,Rex S et al . Long- term benefits of biventricular pacing in con gestive heart failure: resttlts from the multisite stimulation in cardiomyopathy (MUS TIC ) study. J Am Coll Cardiol,21X/2,40(1) : 111
4Henke A,Zell R,Martin V,et al.Direct interferon-γ mediated protection caused by a recombinant coxsackievirus B3[J].Virology,2003,315(2):335-344.
5Song MM,Shuai K. The suppressor of cytokine signaling(socs)1 and socs3 but not socs2 proteins inhibit interferon-mediated antiviral and antiproliferative activities[J].J Biol Chem,1998,273(52):35056-35062.
6Rui T,Yang Yz,Guo Q, et al.Effect of astragalus memberanceus on electrophysiological activities in mice[J].Chin Med Sci J,1993,8:203-205.
7Lutton CW,Gauntt CJ.Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice[J].Interferon Res,1985,5:137-146.
8Wessely R,Klingel K,Knowlton KU,et al.Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling implications for mortality and early viral replication[J].Circulation,2001,103:756-761.
9Krebs DL,Hilton DJ.SOCS:physiological suppressors of cytokines signaling[J].J Cell Sci,2000,113(16):2813-2816.
10Cooney RN.Suppressors of cytokine signaling(SOCS):inhibitors of the JAK/STAT pathway[J].Shock,2002,17(2):83-90.
9Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research[J]. J Am Coll Cardiol, 2002, 39(2): 210.
10Lucas DL, Brown RA, Wassef M, et al. Alcohol and the cardiovascular system research challenges and opportunities[J]. J Am Coll Cardiol, 2005, 45(12): 1916.
